- 1. 3-ketobutyrate
- [ ] (UMLS (CSP) C0220778) =Organic Chemical
| - 47. keratohyalin
- [ ] (UMLS (CSP) C0064295) =Amino Acid, Peptide, or Protein
|
- 2. 510 (K) exempt
- (UMLS (HL7) C1548592) =Idea or Concept =Marketing basis;
| - 48. keratomalacia
- [dryness with ulceration and perforation of the cornea, with absence of inflammatory reactions, occurring in cachectic children; results from severe vitamin A deficiency. ( CSP )] (UMLS (CSP) C0152455) =Disease or Syndrome =cornea;
|
- 3. KE
- [A country in Eastern Africa, bordering the Indian Ocean, between Somalia and Tanzania. (NCI) ( NCI )] (UMLS (NCI) C0022558) =Geographic Area ;
| - 49. Keratomeleusis
- [ ] (UMLS (ICD9CM) C0339022) =Therapeutic or Preventive Procedure
|
- 4. Kechan
- (UMLS (HL7) C1555636) Quechan;
=Language =River;
| - 50. Keratopathy
- (UMLS (NCI) C0235270) =Disease or Syndrome
|
- 5. Keeshond
- [Keeshonden are compact little animals with a strong resemblance to its ancestor the Samoyed, with oblique chestnut eyes, and erect triangular ears. It has a cream or pale gray undercoat and an outer coat that comes in shades of gray with black tips and stands away from the body. The markings are quite definite and there are distinctive pale "spectacles" around the eyes. Height: 17-19 inches (44-48 cm.) Weight: some sources say 55-66 pounds (25-30kg.) while others say 35-45 pounds (15-20 kg.) ( NCI )] (UMLS (NCI) C0324389) =Mammal
| - 51. keratophakia
- [ ] (UMLS (CSP) C0197448) =Therapeutic or Preventive Procedure
|
- 6. Keflin
- (UMLS (NCI) C0733789) =Organic Chemical; Antibiotic ;
| - 52. KERATOPROSTHESIS
- [ ] (UMLS (ICD9CM) C0176217) =Therapeutic or Preventive Procedure
|
- 7. Kefzol
- (UMLS (NCI) C0700925) =Organic Chemical; Antibiotic ;
| - 53. keratosis
- [overgrowth of the upper layer of the skin that is rough, scaly, or gritty in texture, such as a callus or wart. ( CSP )] (UMLS (CSP) C0022593) =Disease or Syndrome ;
=Cutaneous Disorder;
=cholesteatoma;
Darier's disease;
cholesteatoma;
Ichthyosis;
Darier's disease;
Keratoderma, Palmoplantar;
Basal Cell Papilloma;
Parakeratosis;
Porokeratosis;
Callosities;
|
- 8. Keisho-To
- [A botanical formulation with potential chemopreventive activities. Sho-Saiko-to, an herbal mixture containing seven herbal extracts, whose mechanism of action if not fully understood, has shown antiproliferative effects against hepatocellular carcinoma in vitro; other effects described in animal models include the prevention of liver injury and hepatocyte-regenerating activity. Antitumor effects associated with this herbal product may include induction of apoptosis, cell cycle arrest at the G0/G1 phase and activation of an immune response, characterized by the release of cytokines as well as activation of effector cells, such as macrophages and natural killer cells. ( NCI )] (UMLS (NCI) C1138004) Minor Bupleurum Formula;
Sho-Saiko-To;
Xiao Chai Hu Tang;
Xiao-Chai-Hu-Tang;
=Pharmacologic Substance ;
| - 54. Keratosis of Larynx
- (UMLS (NCI) C0392050) =Disease or Syndrome ;
|
- 9. Kell system
- [Multiple erythrocytic antigens that comprise at least three pairs of alternates and amorphs, determined by one complex gene or possibly several genes at closely linked loci. The system is important in transfusion reactions. Its expression involves the X-chromosome. ( MSH )] (UMLS (CSP) C0022546) =Body System ;
| - 55. Keratotic Basal Cell Carcinoma
- (UMLS (NCI) C1304299) Pilar Basal Cell Carcinoma;
Skin Keratotic Basal Cell Carcinoma;
=Neoplastic Process |
- 10. keloid
- [progressively enlarging scar resulting from formation of excessive amounts of collagen in the dermis during connective tissue repair; spreads to surrounding tissues. ( CSP )] (UMLS (NCI) C0022548) =Acquired Abnormality ;
=cicatrix;
Collagen Diseases;
Cutaneous Disorder;
=Acne Keloid | - 56. Keratotic Plaque
- [(loo-ko-PLAY-kee-a) A white patch that may develop on mucous membranes such as the cheek, gums, or tongue and may become cancerous. ( NCI )] (UMLS (NCI) C0023531) =Neoplastic Process ;
=Precancerous Condition;
=Leukokeratosis of Oral Mucosa |
- 11. Kemadrin
- (UMLS (NCI) C0022550) =Organic Chemical; Pharmacologic Substance
| - 57. Keratotic Vocal Cord
- (UMLS (NCI) C0264313) =Neoplastic Process
|
- 12. Kemerovo virus
- [A serotype, in the species Great Island virus, of antigenically related tick-borne viruses found in Eastern Europe, Egypt, and Sudan. ( MSH )] (UMLS (CSP) C0022551) =Virus ;
| - 58. Keresan
- (UMLS (HL7) C1699745) =Language ;
=AmericanIndianAlaskaNativeLanguages;
=Acoma-Laguna;
Eastern Keres Pueblo |
- 13. Kenaitze Indian Tribe
- (UMLS (HL7) C1550889) =Population Group =NativeEntityAlaska;
| - 59. Kerlone
- (UMLS (NCI) C0678122) =Organic Chemical; Pharmacologic Substance ;
|
- 14. Kenalog
- (UMLS (NCI) C0699689) =Steroid; Pharmacologic Substance
| - 60. Kernicterus due to isoimmunization of fetus or newborn
- [ ] (UMLS (ICD9CM) C0270204) =Disease or Syndrome
|
- 15. Kenny Caffey syndrome
- [ ] (UMLS (CSP) C0265291) =Congenital Abnormality; Disease or Syndrome
| - 61. Kernicterus of fetus or newborn not due to isoimmunization
- [ ] (UMLS (ICD9CM) C0158978) =Disease or Syndrome ;
|
- 16. Kentucky
- [A state in the north central United States. Its capital is Frankfort. ( NCI )] (UMLS (NCI) C0022557) =Geographic Area ;
| - 62. kerosene
- [A refined petroleum fraction used as a fuel as well as a solvent. ( MSH )] (UMLS (CSP) C0022611) =Substance ;
|
- 17. kepone
- [ ] (UMLS (CSP) C0878176) =Organic Chemical; Hazardous or Poisonous Substance
| - 63. Kerry Blue Terrier
- [The Kerry Blue Terrier is a well-built, muscular, medium-sized dog with true terrier style and character. It has a long head with abundant whiskers, beard and eyebrows. The ears are v-shaped and crease above the skull to fall toward the outside corner of the eye. The coat is black at birth but changes color through one or more transitions. The mature color is from slate blue to light gray. Height: 171/2-20 inches (44-51 cm.) Weight: 33-40 pounds (15-18 kg.) ( NCI )] (UMLS (NCI) C0324390) =Mammal
|
- 18. Keppra
- (UMLS (NCI) C0876060) =Organic Chemical; Pharmacologic Substance
| - 64. ketal
- [condensation product of an alcohol plus a carbonyl group in anhydrous acid, having the general form R2-C-(OR)2; acetals have the form R-CH-(OR). ( CSP )] (UMLS (CSP) C0596810) =Organic Chemical ;
=ETHER;
|
- 19. keratan sulfate
- [poly(galactose-N-acetylglucosamine sulfate), an important component of the proteoglycan of cartilage and other tissues. ( CSP )] (UMLS (NCI) C0022563) =Carbohydrate; Biologically Active Substance =sulfomucopolysaccharide;
| - 65. Ketalar
- (UMLS (NCI) C0022613) =Organic Chemical; Pharmacologic Substance
|
- 20. Keratan Sulfate Biosynthesis
- [The chemical reactions and pathways resulting in the formation of keratan sulfate, a glycosaminoglycan with repeat units consisting of beta-1,4-linked D-galactopyranosyl-beta-(1,4)-N-acetyl-D-glucosamine 6-sulfate and with variable amounts of fucose, sialic acid and mannose units; keratan sulfate chains are covalently linked by a glycosidic attachment through the trisaccharide galactosyl-galactosyl-xylose to peptidyl-threonine or serine residues. [ISBN:0198547684, RESID:AA0247] ( GO )] (UMLS (NCI) C1156904) Keratan Sulfate Biosynthesis Pathway;
=Molecular Function | - 66. KETAMINE
- [rapid-acting general anesthetic, animal anesthetic, and emerging drug of abuse. ( CSP )] (UMLS (NCI) C0022614) =Organic Chemical; Pharmacologic Substance =[CN200] ANESTHETICS;
cyclohexane;
cyclohexanone;
[CN203] GENERAL ANESTHETICS, OTHER =Ketamine HCl |
- 21. keratin
- [family of cystine-rich proteins that tend to aggregate in side-to- side fashion, forming tough filaments or sheets; main constituent of intermediate filaments in epidermal tissues. ( CSP )] (UMLS (CSP) C0022564) =Amino Acid, Peptide, or Protein; Biologically Active Substance =cytoskeletal protein;
fibrous protein | - 67. Ketamine HCl
- [The hydrochloride salt form of ketamine, a cyclohexanone derivative with analgesic and anesthetic properties. Although its mechanism of action is not well understood, ketamine appears to block N-methyl-D-aspartate (NMDA) receptors and may interact with sigma receptors, thereby reducing pain perception and inducing sedation. ( NCI )] (UMLS (NCI) C0700541) =Organic Chemical; Pharmacologic Substance =KETAMINE;
=KETAMINE HYDROCHLORIDE 100 MG/ML;
KETAMINE HYDROCHLORIDE 10 MG/ML;
KETAMINE HYDROCHLORIDE 50 MG/ML |
- 22. Keratin 19 Gene
- [This gene plays a role in cytoskeletal regulation and the corresponding cellular morphology. ( NCI )] (UMLS (NCI) C1334314) KRT19;
KRT19 Gene;
=Gene or Genome ;
| - 68. Ketchikan Indian Corporation
- (UMLS (HL7) C1550890) =Population Group =NativeEntityAlaska;
|
- 23. Keratin Filament
- [A class of intermediate filaments that form a network within epithelial cells and anchor to desmosomes, thus imparting tensile strength to the tissue ( NCI )] (UMLS (NCI) C1268448) =Cell Component; ;
| - 69. Ketek
- (UMLS (NCI) C1452484) =Organic Chemical; Antibiotic
|
- 24. Keratin Pearls Formation
- (UMLS (NCI) C0334031) =Cell or Molecular Dysfunction
| - 70. ketene
- [general form R2-C=C=O; ketene gas is H2-C=C=O, and is used as an acetylating agent. ( CSP )] (UMLS (CSP) C0124568) =Organic Chemical =KETONE;
acylating agent |
- 25. KERATIN RIDGE MUCOSA-MIN
- [ ] (UMLS (ICD9CM) C1456227) Minimal keratinized residual ridge mucosa;
=Disease or Syndrome ;
| - 71. keto fatty acid
- [ ] (UMLS (CSP) C0596811) =Lipid; Biologically Active Substance
|
- 26. Keratinizing Epidermoid Carcinoma in situ of Nasopharynx
- (UMLS (NCI) C0862753) Keratinizing Epidermoid Carcinoma in situ of the Nasopharynx;
Keratinizing Squamous Cell Carcinoma in situ of Nasopharynx;
Keratinizing Squamous Cell Carcinoma in situ of the Nasopharynx;
Nasopharyngeal Keratinizing Epidermoid Carcinoma in situ;
Nasopharyngeal Keratinizing Squamous Cell Carcinoma in situ;
Nasopharynx Keratinizing Epidermoid Carcinoma in situ;
Nasopharynx Keratinizing Squamous Cell Carcinoma in situ;
Stage 0 Keratinizing Epidermoid Carcinoma of Nasopharynx;
Stage 0 Keratinizing Epidermoid Carcinoma of the Nasopharynx;
Stage 0 Keratinizing Squamous Cell Carcinoma of Nasopharynx;
Stage 0 Keratinizing Squamous Cell Carcinoma of the Nasopharynx;
Stage 0 Nasopharyngeal Keratinizing Epidermoid Carcinoma;
Stage 0 Nasopharyngeal Keratinizing Squamous Cell Carcinoma;
Stage 0 Nasopharynx Keratinizing Epidermoid Carcinoma;
Stage 0 Nasopharynx Keratinizing Squamous Cell Carcinoma =Neoplastic Process | - 72. ketoaldehyde
- [ ] (UMLS (CSP) C0596812) =Organic Chemical ;
|
- 27. Keratinizing Epidermoid Carcinoma of Nasopharynx
- [A nasopharyngeal carcinoma showing squamous differentiation in the form of intercellular bridges or keratinization over most of its extend (Sternberg's Diagnostic Surgical Pathology, 3rd ed., 1999). —2002 ( NCI )] (UMLS (NCI) C0279698) =Neoplastic Process
| - 73. ketogenesis
- [ ] (UMLS (CSP) C0599816) =Molecular Function ;
|
- 28. Keratinizing Primary Intraosseous Squamous Cell Carcinoma Arising de novo
- (UMLS (NCI) C1334322) Keratinizing Primary Intraosseous Squamous Cell Carcinoma -Solid Type =Neoplastic Process ;
| - 74. ketogenic
- [ ] (UMLS (CSP) C0599817) =Molecular Function ;
|
- 29. Keratinizing Squamous Cell Carcinoma
- [Squamous cell carcinomas with morphologically prominent production of keratin. ( NCI )] (UMLS (NCI) C0334247) =Neoplastic Process
| - 75. ketoglutarate dehydrogenase
- [ ] (UMLS (CSP) C0599061) =Amino Acid, Peptide, or Protein; Enzyme ;
|
- 30. Keratinocyte
- [vertebrate, epidermal cell of ectodermal origin. ( CSP )] (UMLS (NCI) C0022567) =Cell ;
= ;
Integument | - 76. ketone oxidoreductase
- [Oxidoreductases that are specific for KETONES. ( MSH )] (UMLS (CSP) C0022632) =Amino Acid, Peptide, or Protein; Enzyme
|
- 31. Keratinocyte Differentiation
- [Differentiation of keratinocytes to the fully differentiated keratinocyte phenotype. ( NCI )] (UMLS (NCI) C1159909) =Cell Function
| - 77. KETOROLAC TROMETHAMINE
- [The tromethamine salt of ketorolac, a synthetic pyrrolizine carboxylic acid derivative with anti-inflammatory, analgesic and antipyretic properties. Ketorolac tromethamine, a non-selective inhibitor of the cyclooxygenases (COX), inhibits both COX-1 and COX-2 enzymes. This agent exerts its anti-inflammatory effect by preventing conversion of arachidonic acid to prostaglandins at inflammation site mediated through inhibition of COX-2, undetectable in most tissues but is up-regulated at the inflammation sites by cytokines stimulation. Since COX-1 is expressed virtually in all tissues, inhibition of COX-1 enzyme by this agent prevents normal state production of prostaglandins, which plays housekeeping roles in the protection of the gastrointestinal tract, regulating renal blood flow, and functioning in platelet aggregation. As a result, inhibition of COX-1 is usually associated with adverse effects such as gastrointestinal toxicity and nephrotoxicity. ( NCI )] (UMLS (NCI) C0064326) =Organic Chemical; Pharmacologic Substance ;
=1-(4-chlorobenzoyl)-5-methoxy- 2-methyl-1-H-indole-3-acetic acid;
KETOROLAC =KETOROLAC TROMETHAMINE 0.5 %;
KETOROLAC TROMETHAMINE 10 MG;
KETOROLAC TROMETHAMINE 15 MG/ML;
KETOROLAC TROMETHAMINE 30 MG/ML;
|
- 32. keratinocyte growth factor
- [A fibroblast growth factor that is a specific mitogen for EPITHELIAL CELLS. It binds a complex of HEPARAN SULFATE and FIBROBLAST GROWTH FACTOR RECEPTOR 2B. ( MSH )] (UMLS (CSP) C0064294) =Amino Acid, Peptide, or Protein; Biologically Active Substance ;
| - 78. ketosteroid
- [Steroid derivatives formed by oxidation of a methyl group on the side chain or a methylene group in the ring skeleton to form a ketone. ( MSH )] (UMLS (CSP) C0022640) =Steroid ;
=Steroid;
=17-Ketosteroids |
- 33. Keratinocyte Growth Factor Therapy
- (UMLS (NCI) C0677833) =Therapeutic or Preventive Procedure ;
| - 79. ketotic glycinemia
- [elevated accumulation and excretion of glycine accompanied by ketosis that is secondary to methylmalonicacidemia, isovalericacidemia and other organic acidemias, as distinguished from nonketotic hyperglycinemia. ( CSP )] (UMLS (CSP) C0268579) =Disease or Syndrome =enzyme deficiency;
hyperglycinemia |
- 34. Keratinous Cyst of Scrotum
- (UMLS (NCI) C0341789) =Finding
| - 80. KETOTIFEN
- [A cycloheptathiophene derivative with anti-allergic activity. Ketotifen selective blocks histamine (H1) receptors and prevents the typical symptoms caused by histamine release. This agent also interferes with the release of inflammatory mediators from mast cells involved in hypersensitivity reactions, thereby decreasing chemotaxis and activation of eosinophils. ( NCI )] (UMLS (NCI) C0022642) =Organic Chemical; Pharmacologic Substance =Piperidines;
Thiophenes;
[OP900] OPHTHALMICS, OTHER;
=10H-Benzo(4,5)cyclohepta(1,2-b)thiophen-10-one, 4,9-dihydro-4-(1-methyl-4-piperidinylidene)-,(E)-2-butenedioate(1:1) |
- 35. keratitis
- [inflammation of the cornea. ( CSP )] (UMLS (CSP) C0022568) =Disease or Syndrome ;
=cornea;
=BETZURINGOKO ULTZERA(INKL.HERPESA);
keratoconjunctivitis;
Acanthamoeba keratitis;
BETZURINGOKO ULTZERA(INKL.HERPESA);
Keratitis, Herpetic;
keratoconjunctivitis;
| - 81. Ketrax
- (UMLS (NCI) C0733387) =Organic Chemical; Pharmacologic Substance
|
- 36. KERATITIS IN EXANTHEMA
- [ ] (UMLS (ICD9CM) C0155086) =Disease or Syndrome
| - 82. Kevadon
- (UMLS (NCI) C0729006) =Organic Chemical; Pharmacologic Substance; Hazardous or Poisonous Substance
|
- 37. KERATITIS NEC
- [ ] (UMLS (ICD9CM) C0348526) =Disease or Syndrome
| - 83. Keweenaw Bay Indian Community of L'Anse and Ontona
- (UMLS (HL7) C1554341) =Population Group =NativeEntityContiguous;
|
- 38. Keratoacanthoma
- [benign papular lesion with a superficial crater filled with a keratin plug, usually on the face. ( CSP )] (UMLS (NCI) C0022572) =Neoplastic Process ;
=Cutaneous Disorder;
| - 84. Key
- [Key - this message element is used as a key to set or collection of message elements ( HL7V3.0 )] (UMLS (HL7) C1554080) =Idea or Concept =HL7UpdateMode;
|
- 39. keratocentesis
- [ ] (UMLS (CSP) C0197430) =Therapeutic or Preventive Procedure ;
| - 85. keyhole limpet hemocyanin
- [KLH. One of a group of drugs called immune modulators, given as a vaccine to help the body respond to cancer. ( NCI )] (UMLS (NCI) C0064332) =Amino Acid, Peptide, or Protein; Biologically Active Substance ;
|
- 40. KERATOCONJUNCTIVIT SICCA
- [ ] (UMLS (ICD9CM) C0155082) =Disease or Syndrome ;
| - 86. Keyhole Limpet Hemocyanin/MUC-1 Antigen
- (UMLS (NCI) C0338357) =Therapeutic or Preventive Procedure ;
|
- 41. keratoconjunctivitis
- [simultaneous inflammation of the cornea and conjunctiva. ( CSP )] (UMLS (CSP) C0022573) =Disease or Syndrome ;
=conjunctivitis;
keratitis =KCS;
Keratoconjunctivitis, Infectious;
| - 87. Keyhole Limpet Hemocyanin/MUC-1 Antigen/QS21
- (UMLS (NCI) C0879368) =Therapeutic or Preventive Procedure ;
|
- 42. KERATOCONJUNCTIVITIS NEC
- [ ] (UMLS (ICD9CM) C0029650) =Disease or Syndrome ;
| - 88. Keyhole Limpet Hemocyanin/Polysialic Acid
- (UMLS (NCI) C0879413) =Therapeutic or Preventive Procedure
|
- 43. keratoconus
- [noninflammatory, usually bilateral protrusion of the cornea in which the apex is displaced downward and nasally; the conus refers to the cone shape of the corneal protrusion. ( CSP )] (UMLS (CSP) C0022578) =Disease or Syndrome ;
=cornea;
| - 89. Keyhole Limpet Hemocyanin/Polysialic Acid/QS21
- (UMLS (NCI) C0879414) =Therapeutic or Preventive Procedure
|
- 44. KERATOCONUS, AC HYDROPS
- (UMLS (ICD9CM) C0339286) =Disease or Syndrome ;
| - 90. Keyhole Limpet Hemocyanin/QS21/Sialyl Tn Antigen
- (UMLS (NCI) C0281744) =Therapeutic or Preventive Procedure
|
- 45. KERATOCONUS, STABLE
- [ ] (UMLS (ICD9CM) C0155131) =Disease or Syndrome
| - 91. Keyhole Limpet Hemocyanin/Sargramostim
- (UMLS (NCI) C0935862) =Therapeutic or Preventive Procedure ;
|
- 46. Keratoderma
- (UMLS (NCI) C0022579) =Congenital Abnormality ;
| - 92. Keyhole-Limpet Hemocyanin Fluorescein Isothiocyanate Conjugate
- [A compound containing keyhole-limpet hemocyanin (KLH) conjugated with fluorescein isothiocyanate (FITC) with potential immunostimulating activity. Vaccination with KLH-FITC may elicit an immune response against the fluorescein dye and may lead to production of anti-fluorescein IgG antibodies. Keyhole limpet hemocyanin, a natural protein isolated from the marine mollusk keyhole limpet, is an immunostimulant carrier protein that may increase the immune response against fluorescein. ( NCI )] (UMLS (NCI) C0257324) =Amino Acid, Peptide, or Protein; Pharmacologic Substance
|
home
